RAD-140 (Testolone) is available from Kimerachems for controlled laboratory and analytical research. Review the product-specific information, available formats and documentation below before ordering.
RAD-140 (Vosilasarm / Testolone) Research Standard
RAD-140, also known as Vosilasarm (Testolone), is a synthetic nonsteroidal selective androgen receptor modulator (SARM) with high-affinity binding characteristics for the androgen receptor (AR). Originally developed for its tissue-specific anabolic properties, it has advanced into clinical investigation, particularly for the treatment of AR-positive hormone-sensitive breast cancer. In laboratory settings, RAD-140 serves as a high-precision reference standard for studying nuclear receptor signaling, structure-activity relationships (SAR) within the benzonitrile-oxadiazole class, and the development of analytical methods for detecting Selective Modulators in complex matrices.
Technical Specifications
| Property | Specification |
| Product Name | RAD-140 (Vosilasarm / Testolone) |
| IUPAC Name | 2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile |
| CAS Number | 1182367-47-0 |
| Chemical Formula | C₂₀H₁₆ClN₅O₂ |
| Molecular Weight | 393.83 g/mol |
| Chemical Class | Nonsteroidal benzonitrile / 1,3,4-oxadiazole SARM |
| Physical Appearance | White to off-white solid |
| Binding Affinity | Ki ≈ 7 nM |
Mechanism of Action & Research Context
RAD-140 functions as a tissue-differential ligand, meaning it elicits distinct transcriptional outcomes depending on the receptor environment and coregulator recruitment.
-
Receptor Binding: RAD-140 exhibits high affinity for the androgen receptor ligand-binding domain. Its interaction promotes a unique conformational shift distinct from endogenous steroidal androgens, which is a primary focus of structural biology studies.
-
Transcriptional Output: Research demonstrates full-agonist activity in muscle- and bone-derived cell models, while exhibiting partial-agonist or suppressive activity in other tissue types.
-
Oncology Research: In AR+/ER+ breast cancer research, the compound is studied for its dual role: acting as an AR agonist while simultaneously suppressing ER-mediated signaling and downregulating ESR1 mRNA expression.
-
Metabolic Profile: Preclinical data identifies hepatic metabolism via oxidation and conjugation pathways, providing a framework for ADME (Absorption, Distribution, Metabolism, and Excretion) studies in isolated liver models.
Research Applications
RAD-140 is a widely recognized reference standard for advanced pharmacological and analytical research.
Primary fields of in vitro laboratory investigation include:
-
Androgen Receptor Signaling: Utilizing competitive binding and transactivation assays to map AR-ligand interaction dynamics.
-
Oncology & Nuclear Receptor Crosstalk: Investigating the interaction between AR and ER pathways in hormone-sensitive breast cancer models.
-
Analytical Method Development: Serving as a primary reference standard for LC-MS/MS protocols in anti-doping forensic toxicology.
-
SAR Analysis: Evaluating how the oxadiazole heterocycle and nitrile substituents contribute to receptor selectivity and metabolic stability.
-
Toxicological Assessment: Analyzing hepatotoxicity potential and cellular stress markers in response to prolonged ligand exposure.
Storage & Handling Guidelines
To maintain the chemical stability and experimental reliability of the compound:
-
Long-Term Storage: Store in a dry, cool environment. For maximum stability, maintain at -20 °C.
-
Atmospheric Control: Keep the container tightly sealed to prevent degradation.
-
Light Sensitivity: Protect from direct light to preserve the integrity of the benzonitrile-oxadiazole scaffold.
-
Aseptic Technique: Utilize clean, non-reactive laboratory equipment to prevent contamination, particularly when preparing stock solutions for binding assays.
Regulatory & Research Note
RAD-140 is designated as a prohibited substance on the World Anti-Doping Agency (WADA) list. Researchers involved in anti-doping analytical chemistry use this compound as a certified reference material for developing detection methods for non-medical use. The compound is under active clinical study (e.g., EP0062) for oncological indications; it is not approved for any consumer, medical, or dietary application.
Research Use Disclaimer
Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.
| CAS Number | 1182367-47-0 |
| Other Names | Testolone, RAD140, RAD 140, Vosilasarm, 4O87Q44KNC, CHEMBL1672635, D09ZLZ |
| IUPAC Name | 2-chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile |
| Molecular Formula | C₂₀H₁₆ClN₅O₂ |
| Molecular Weight | 393.8 |
| Liquid Concentration And Solution | 30mg/ml PEG400, DMSO |
| Aliquot Concentration And Solution | 50mg/ml (PEG400, Propylene Glycol, Benzyl benzoate, Benzyl Alcohol) |
Product FAQs
What is RAD-140 (Testolone) supplied for?
This material is supplied strictly for controlled, non-clinical laboratory and analytical research. It is not intended for human or animal consumption.
Which formats are available for RAD-140 (Testolone)?
The current listing shows these options: 1 Gram Powder, Aliquot 10ml Vial (Advanced Carrier Blend) 10ml/50mg Per ml/500mg, Dry-Fill Capsule 10mg/60ct/600mg, Liquid 30ml/30mg Per ml/900mg, tablets-20mg-30ct-600mg. Availability can change, so confirm the selector above before ordering.
Where can I review product documentation?
Where available, batch documentation can be reviewed in the Certificate of Analysis library before ordering.




